Nonspecific suppression of [3H]thymidine incorporation by "control" oligonucleotides
- PMID: 1292780
- DOI: 10.1089/ard.1992.2.325
Nonspecific suppression of [3H]thymidine incorporation by "control" oligonucleotides
Abstract
Phosphodiester oligonucleotides are rapidly degraded in spleen cell cultures. The present studies were conducted to determine whether thymidine released from degradation of such oligonucleotides could be reutilized and compete with [3H]thymidine incorporation, thereby causing nonspecific inhibition of "proliferation" assays. Our studies in mitogen-stimulated mouse spleen cells demonstrate that "control" oligonucleotides that contain thymidine can cause more than 90% inhibition of [3H]thymidine incorporation. This inhibitory effect was generally dependent on the location of the thymidine within the oligonucleotide: oligonucleotides that had 3'-terminal thymidine(s) caused more suppression than those in which thymidines were at the 5' end. All oligonucleotides caused a modest but variable inhibition of [3H]uridine incorporation. Furthermore, [3H]thymidine incorporation was partially inhibited even by oligonucleotides that did not contain thymidine. We propose that investigators who use [3H]thymidine incorporation assays to assess antisense effects do so with caution. It may be prudent to use control oligonucleotides with the same number and location of thymidine bases and to confirm [3H]thymidine incorporation assays with other measures of cell proliferation.
Similar articles
-
Calcium channel blockers inhibit cellular uptake of thymidine, uridine and leucine: the incorporation of these molecules into DNA, RNA and protein in the presence of calcium channel blockers is not a valid measure of lymphocyte activation.Immunopharmacology. 1993 Jan-Feb;25(1):75-82. doi: 10.1016/0162-3109(93)90032-l. Immunopharmacology. 1993. PMID: 7686541
-
Erroneous results of 3H-thymidine incorporation are related to position of thymidine residues in oligodeoxynucleotides.Exp Hematol. 1994 Apr;22(4):384-7. Exp Hematol. 1994. PMID: 8150038
-
Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.Antisense Res Dev. 1993 Spring;3(1):53-66. doi: 10.1089/ard.1993.3.53. Antisense Res Dev. 1993. PMID: 8495106
-
The effect of normal spleen cells on 3H-thymidine uptake by target cells in vitro.Br J Exp Pathol. 1975 Jun;56(3):223-30. Br J Exp Pathol. 1975. PMID: 1191518 Free PMC article.
-
Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1048-52. doi: 10.1073/pnas.90.3.1048. Proc Natl Acad Sci U S A. 1993. PMID: 8430072 Free PMC article.
Cited by
-
Preclinical and clinical pharmacology of antisense oligonucleotides.Mol Biotechnol. 1999 Aug;12(1):1-11. doi: 10.1385/MB:12:1:1. Mol Biotechnol. 1999. PMID: 10554769 Review.
-
Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.Gut. 2001 Feb;48(2):230-7. doi: 10.1136/gut.48.2.230. Gut. 2001. PMID: 11156646 Free PMC article.
-
Bioavailability of antisense oligonucleotides in neuroblastoma cells: comparison of efficacy among different types of molecules.J Neurooncol. 1997 Jan;31(1-2):171-80. doi: 10.1023/a:1005726623591. J Neurooncol. 1997. PMID: 9049846
-
Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells.Immunology. 2003 Oct;110(2):250-7. doi: 10.1046/j.1365-2567.2003.01722.x. Immunology. 2003. PMID: 14511239 Free PMC article.
-
The arthritogenic and immunostimulatory properties of phosphorothioate oligodeoxynucleotides rely on synergy between the activities of the nuclease-resistant backbone and CpG motifs.Inflammation. 2004 Feb;28(1):39-51. doi: 10.1023/b:ifla.0000014710.44475.94. Inflammation. 2004. PMID: 15072229
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources